Posts

The ADC Cytotoxic Payloads / Warheads market is projected to grow at an annualized rate of 12.4%, till 2030

Image
Roots Analysis has done a detailed report on ADC Cytotoxic Payloads / Warheads: Products and Services Market , 2021-2030 ” covering key aspects of the industry and identifying key future growth opportunities   To order this 130+ page report, which features 50+ figures and 15+ tables, please visit https://www.rootsanalysis.com/reports/adc-cytotoxic-payloads-market.html   Key Market Insights §   Presently, over 40 players are engaged in the development of ADC cytotoxic payloads / warheads. It is worth noting that majority (44%) of the firms engaged in this domain are based in Europe, followed by North America (28%) and Asia Pacific (28%). §   More than 430 patent applications / granted patents have been filed over the last few years. Majority (80%) of the patents were filed / granted in North America; other key regions with significant intellectual capital include regions of Europe and South Korea §   Maximum number of partnerships were established in 2021, indicating

The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers

Image
Several innovative drug delivery technologies have gathered notable momentum (in terms of adoption and sales) soon after entering the market; most of these are designed to address the unmet needs of administering complex pharmacological interventions Roots Analysis has announced the addition of the “ On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles ” report to its list of offerings.   Since the early 20th century, over 12,000 patents / patent applications have been granted / filed in relation to drug delivery devices that can either be worn on the body ( or implanted ), by both industry and non-industry players. Presently, innovation in this domain is focused on developing cheaper and more environment friendly drug delivery systems, with provisions to minimize / altogether eliminate the risk of needlestick injuries.   To